Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Simplifying changes requires clear steps and reminders. Learn practical ways to make mid-month edits that stick and save you time.
23,956 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A tech giant lanes three high-margin engines—cloud, ads, and subscriptions—on a profitable retail base, challenging m...
The S&P 500 has fallen 2.5% this month, but Gabelli Multimedia Trust and Trinity Capital have held steady. Their inco...
Oil prices edge up near the mid-$90s on June 1, 2026, as traders weigh supply risks and summer demand. Brent sits aro...
The S&P 500 is up this year, but history offers guidance on what comes next. Learn the patterns, risks, and practical...
Crypto social activity just fell to a multi-month low, signaling a rare lull in online chatter. Analysts say this qui...
A one-time lottery windfall can trigger IRMAA surcharges, lifting Medicare premiums for the following year. Here's ho...
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...
Investors have watched robinhood stock been volatile as the company transitions from breakneck growth to a steadier, ...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
New York City honors Jack Kirby with a street-name dedication on a Lower East Side block, recognizing the immigrant a...
A new UT Austin study finds pandemic relief funds accidentally boosted housing demand in several markets, lifting loc...